Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Don Miller who wrote (1945)	3/5/1999 3:23:00 PM
From: Neuroguy	Read Replies (2) \| Respond to of 10280

I'd be positively dejected if JNJ picked off SEPR for 155. Consider what this looks like in terms of earnings and growth over the next 5-9 years, and compare that to JNJ.... You couldn't pay me to hold JNJ long in deference to other investments. I sincerely hope that SEPR has the appropriate safeguards in place to prevent this. Seems likely that institutional holders like Fidelity would use whatever resources they have available to block such a move. Of course, for JNJ, it makes perfect sense.